September 16, 2014: Eagle Biosciences recently announced a North American distribution agreement with ImmuSmol, Inc. of France. ImmuSmol develops and manufactures research antibodies and esoteric assays in a variety of research fields. They strive to be the best in the industry by selecting antibodies for their specificity and binding affinity by ELISA and systematically validating for IHC.They have a strong expertise in antigen design and a solid focus for targeting low molecular weight molecules which are not typically addressed by antibodies such as amino acid metabolites, lipids, saccharides, toxins, pesticide residues, and small molecule drugs.
“ImmuSmol products bring tremendous value to EagleBio and more specifically our line of antibodies.” said Dan Keefe President of EagleBio. He continued, “A partnership with ImmuSmol provides us with not only robust, high quality antibodies, but it also links EagleBio to a niche market for the detection of small molecules in cells, tissues, and biological fluids.” Keefe added, “There are so many small molecules that could serve as potential drug targets but have yet to be studied in this way. We certainly plan to stay abreast of the developments in the ImmuSmol pipeline and continue to offer new products in emerging areas of research.”
These products are currently for research use only. Check out the list of new ImmuSmol antibodies below, visit the Eagle website www.EagleBio.com, or call 866-411-8023 for full details.